Join Us

Project Access

Project Access Navigation
  • Home
  • About
  • Policy
  • Donate
  • Resource Guide
  • Search
  • Home
  • About
  • Policy
  • Donate
  • Resource Guide
  • Search

Veklury (remdesivir) A Preferred Antiviral Drug to Treat COVID-19

Veklury (remdesivir) is an antiviral drug that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults and pediatric patients (28 days of age and older and weighing at least 3 kg). Read More

  • Privacy Policy
  • Terms of Service
  • Donate
  • Contact
Project Access is a program of The National Center for Public Policy Research (NCPPR).
© 2024 NCPPR. All Rights Reserved.